-+ 0.00%
-+ 0.00%
-+ 0.00%

AMNEAL RECEIVES U.S. FDA APPROVAL FOR BREKIYA® (DIHYDROERGOTAMINE MESYLATE) INJECTION FOR THE ACUTE TREATMENT OF MIGRAINE AND CLUSTER HEADACHES IN ADULTS

Reuters·05/15/2025 12:00:00

Please log in to view news